Skip to main content

Table 4 Correlation of clinicopathological factors and surgical outcomes of patients with or without postoperative liver infarction

From: Is hepatic artery coil embolization useful in distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic cancer?

Factor

Liver infarction (+)

(n = 8)

Liver infarction (−)

(n = 23)

p value

Age (years)

61.5 (42–78)

65.0 (39–80)

0.428

Gender, male/female

5/3

16/7

1.000

CEA (ng/mL)

4.0 (1.0–14.0)

3.3 (0.7–493.0)

0.519

CA19-9 (U/mL)

401.0 (3.3–16,860.0)

235.5 (0.1–3211.0)

0.075

Tumor size (MDCT) (cm)

5.0 (1.7–10.1)

3.0 (1.7–7.4)

0.021

GDA/PHA contact (MDCT), yes/no

6/2

4/19

0.006

Anomaly, yes/no

3/5

9/14

1.000

Neoadjuvant chemotherapy, yes/no

7/1

17/6

0.642

Preoperative coil embolization, yes/no

7/1

16/7

0.642

Duration since coiling to operation (days)

15.0 (4–87)

22.5 (4–104)

0.203

Operative time (min)

434 (313–584)

298 (175–540)

0.005

Blood loss (g)

2130 (365–5455)

1100 (305–10270)

0.448

Blood trans fusion, yes/no

5/3

12/11

0.698

Portal vein resection, yes/no

7/1

9/14

0.037

Gastrectomy, yes/no

3/5

2/21

0.093

Bile duct resection, yes/no

1/7

0/23

0.258

Postoperative portal vein stenosis, yes/no

5/3

6/17

0.095

GDA/PHA stenosis, yes/no

8/0

3/20

< 0.001

Tumor size (specimen) (cm)

5.6 (2.8–10.0)

4.0 (2.0–6.5)

0.022

Histologic type, well/mod./por./other

3/2/2/1

7/12/2/2

0.505

Lymph node metastasis, yes/no

7/1

17/6

0.642

Arterial invasion, yes/no

5/3

9/14

0.413

Portal vein invasion, yes/no

6/2

15/8

1.000

Perineural invasion, yes/no

7/1

22/1

0.456

Residual tumor status, R0/R1, 2

4/4

9/14

0.689

UICC stage (7th edition), IIA/IIB, III, IV

0/8

6/17

0.298

Morbidity*, C–D I, II/C–D III, IV, V

1/7

9/14

0.222

Pancreatic fistula**, None, grade A/grade b, C

3/5

11/12

0.698

Liver abscess, yes, no

1/7

0/23

0.258

Postoperative hospital stay (days)

47.5 (26–182)

34.0 (16–97)

0.037

  1. All results are shown as median (range) or number
  2. UICC Union for International Cancer Control
  3. *According to Clavien–Dindo (C–D) classification (ver. 2.0)
  4. **According to International Study Group of Pancreatic Surgeons